Autor Engelhard, Marianne
-
2009 | Zeitschriftenartikel
Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma
Herrmann, A.; Hoster, E.; Zwingers, T.; Brittinger, G.; Engelhard, M.; Meusers, P. & Reiser, M. u.a. (2009)
Journal of Clinical Oncology, 27(4) pp. 511-518. DOI: https://doi.org/10.1200/JCO.2008.16.8435
Details DOI PMID PMC WoS
-
2012 | Konferenzbeitrag (Abstract)
Treatment of Early Stage Nodal Follicular Lymphoma Using Involved-Field Radiotherapy and Rituximab: Preliminary Results of the Mir Trial (phase II study of the German Low Grade Lymphoma Study Group (GLSG))
Herfarth, K.; Engelhard, M.; Borchmann, P.; Hohloch, K.; Budach, V.; Viardot, A. & Witzens-Harig, M. u.a. (2012)
Blood, 120(21) , Atlanta, GA.
Washington: Amer Soc Hematology.
Details WoS
-
2018 | Zeitschriftenartikel
Rituximab With Involved Field Irradiation for Early-stage Nodal Follicular Lymphoma
Herfarth, K.; Borchmann, P.; Schnaidt, S.; Hohloch, K.; Budach, V.; Engelhard, M. & Viardot, A. u.a. (2018)
HemaSphere, 2(6) pp. e160. DOI: https://doi.org/10.1097/HS9.0000000000000160
Details DOI
-
2019 | Zeitschriftenartikel |
Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro) - GAZAI Trial (GAZyvaro and response adapted Involved-site Radiotherapy): a study protocol for a single-arm, non-randomized, open, national, multi-center phase II trial
König, L.; Dreyling, M.; Dürig, J.; Engelhard, M.; Hohloch, K. ; Viardot, A. & Witzens-Harig, M. u.a. (2019)
Trials, 20(1). DOI: https://doi.org/10.1186/s13063-019-3614-y
Details DOI